DATE: 2012-02-06

New York Times		NPR, Shots		Wall Street Journal		Economic Times, Indiatimes
Sloan-Kettering Chief Is Accused of Taking Research By Andrew Pollack		The 'Morning After' Pill: How It Works And Who Uses It By Patti Neighmond		Charity Does an About-Face Breast-Cancer Group Backs Off Move to Withhold Funds for Planned Parenthood By Louise Radnofsky, Anna Wilde Mathews, Melanie Grayce West		Strides Arcolab may fetch Rs 1250 cr from sale of domestic units By Mohit Bhalla

DATE: 2012-02-03

The Telegraph		New York Times, Well		BBC		Wall Street Journal, Health Blog
Malaria death toll far higher than previously thought By Correspondent		New Vaccine Recommendations for Boys and Diabetics By Anahad O'Connor		Brains may be wired for addiction By James Gallagher		Two Studies Hint at How Alzheimer’s Might Spread By Shirley S. Wang

DATE: 2012-02-02

New York Times		Forbes		Bloomberg Businessweek		The Guardian
Uproar as Breast Cancer Group Ends Partnership With Planned Parenthood By Gardiner Harris, Pam Belluck		Why CEO Replacement Is Good News For Dendreon By Matthew Herper		Medivation Surges on Prostate Cancer Drug: San Francisco Mover By Michelle Fay Cortez, Robert Langreth		Tax and regulate sugar like alcohol and tobacco, urge scientists By Alok Jha

DATE: 2012-02-01

Boston Globe		BBC		The Telegraph		Wall Street Journal
FDA approves Vertex drug for rare form of cystic fibrosis By Deborah Kotz		Contraceptive pill recalled in US By Correspondent		Vaccine to treat breast cancer 'promising' say experts By Rebecca Smith		Gaining on Prostate Cancer Drug Firms Advance Rapidly After Long Drought, but Treatments Are Pricey By Ron Winslow

DATE: 2012-01-31

NPR, Shots		Boston Globe		Forbes		BBC
A Bid To Replace Neglect For Tropical Diseases With Attention By Richard Knox		FDA approves first skin cancer drug By Robert Weisman		Healthcare's Medical Gluttony By Dan Munro		Skin transformed into brain cells By James Gallagher

DATE: 2012-01-30

Boston Globe		NPR, Morning Edition		Economic Times, Indiatimes		Wall Street Journal, Health Blog
Putting care in patients’ hands At MIT, specialists create ways to improve disease management By Karen Weintraub		Could A Club Drug Offer 'Almost Immediate' Relief From Depression? By Jon Hamilton		Fondaparinux injection issue resolved with USFDA: Dr Reddy's Laboratories By IST, PTI		FDA (Finally) Gives Amylin’s Bydureon a Thumbs-Up By Katherine Hobson

DATE: 2012-01-27

Economic Times, Indiatimes		Boston Globe		New York Times, Well		NPR, Shots
Ranbaxy settles row with USFDA; to upgrade plants in India and US By IST, ET Bureau		Studies: Avastin may fight early breast cancers By Marilynn Marchione		Using Symptom Checklists to Sell Drugs By Pauline W. Chen, M.D.		How Health Care Dropped Out Of The Presidential Conversation By Julie Rovner

DATE: 2012-01-26

The Telegraph		Associated Press		Economic Times, Indiatimes		New York Times
Breast implant scandal: PIP founder arrested By Donna Bowater		Illumina adopts takeover defense to ward off Roche By newswire		Dr Reddy's Labs in trouble with US health regulator again By IST, PTI		With Prevalence of Nanomaterials Rising, Panel Urges Review of Risks By Cornelia Dean

DATE: 2012-01-25

Forbes		NPR, It's All Politics		New York Times		Wall Street Journal, Health blog
Roche's Hostile Bid For Illumina Ups Stakes In DNA Tech Race By Matthew Herper		Analysis: Landmark Health Overhaul Gets Barely A Mention By Julie Rovner		Grief Could Join List of Disorders By Benedict Carey		J&J Still Sees Impact of McNeil Recalls, But Brands Are Coming Back By Katherine Hobson, Peter Loftus

DATE: 2012-01-24

Wall Street Journal		NPR, Shots blog		The Guardian, Science blog		Boston Globe
EU Regulator Reviews Novartis MS Pill By Sten Stovall, Jennifer Corbett Dooren		Women Report More Pain Than Men From Same Ailments By Nancy Shute		Diabetes has not been defeated Ninety years after the first use of insulin to treat diabetes, preventable complications and early deaths are a scandal By Barbara Young, CEO, Diabetes UK		Eye study is first involving human stem cells With funding, Marlborough firm has key role By Chelsea Conaboy

DATE: 2012-01-23

Wall Street Journal		Forbes		New York Times		Boston Globe, The Daily Dose
Should Patents on Pharmaceuticals Be Extended to Encourage Innovation? By Josh Bloom, Els Torreele		Stossel is right for demonizing the demonization of physician-industry relationships By Tom Stossel, WSJ; David Shaywitz, Forbes		Scientists to Pause Research on Deadly Strain of Bird Flu By Denise Grady		Reevaluating the benefits of blood thinners By Deborah Kotz

DATE: 2012-01-20

BBC		Boston Globe		Forbes		New York Times
Johnson & Johnson settles $158m US Medicaid fraud case By Correspondent		Mass. biotechs leaping into generic drug market By Robert Weisman		What If Antibiotics Stop Working? Cataclysm By Matthew Herper		New Definition of Autism Will Exclude Many, Study Suggests By Benedict Carey

ABOUT BETSY RAYMOND STEVENSON

Founder and Principal, RaymondStevenson Healthcare Communications (RSHC) >>>

ABOUT RSHC
Building Healthy Relationships

Expert and creative communications services for the pharmaceutical and biotechnology industries. >>>

• Strategic media relations
• Thought leader relations
• Integrated social media relations
• Media interview coaching
• Tactical support
• Issues management
• Global expertise
• Developing world expertise

PROFESSIONAL SOURCES